BridgeBio's valuation relies on the commercialization of Attruby, but the drug's full potential may be undermined by tafamidis’ patent extension, introduction of generic alternatives, and other ...

Interests of minority shareholders in Credit Agricole S.A. could be subservient to its ultimate parent, the Credit Agricole regional banks, and its members. The most valuable part of the Credit ...

Overall, the group’s total revenue declined on CLAS deconsolidation, but the higher fee revenue partially offsets the lower ...